Remco Munnik, Associate Director at Iperion, who helped create the EU IDMP Implementation Guide version 2, explains why pharma companies need to act now in response to the new guidance and provides practical recommendations for action.
By Hannah Balfour (European Pharmaceutical Review)
By Chris Boyle (Sidley Austin), Marie Manley (Sidley Austin)
By Victoria Rees (European Pharmaceutical Review)
By Dr Ioannis Papayannopoulos